CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer

Published:2024-01 Issue: Volume:Volume 13 Page:1-14
ISSN:2253-1556
Container-title:ImmunoTargets and Therapy
language:en
Short-container-title:ITT

Author:

Li Yuchen^ORCID,Gu Yinfeng^ORCID,Yang Pengyue^ORCID,Wang Yan^ORCID,Yu Xibao^ORCID,Li Yangqiu^ORCID,Jin Zhenyi,Xu Ling^ORCID

Publisher

Informa UK Limited

Reference97 articles.

1. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells

2. Is CD69 an effective brake to control inflammatory diseases?

3. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.

4. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

5. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 Deletion Decreases Pristane-induced Inflammation;ImmunoHorizons;2024-09-01

2. High percentage of bone marrow CD8+ tissue-resident-like memory T cells predicts inferior survival in patients with acute myeloid leukemia;Blood Science;2024-06-07

3. High percentage of bone marrow CD8+ tissue-resident-like T cells predicts inferior survival in patients with acute myeloid leukemia;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3